WHO ICTRP trial
A clinical study of remifentanil versus propofol in the treatment of emergence…
ChiCTR2200057412 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200057412 |
|---|---|
| Public title | A clinical study of remifentanil versus propofol in the treatment of emergence agitation in adults |
| Scientific title | A clinical study of remifentanil versus propofol in the treatment of emergence agitation in adults |
| Primary sponsor | The First Affiliated Hospital of USTC |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | emergence agitation |
| Interventions | Remifentanil treatment group:Remifentanil treatment;Propofol treatment group:Propofol treatment |
| Registration date | Mar 11, 2022 |
| Target size | Remifentanil treatment group:76;Propofol treatment group:76 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: